ECRI's 2026 Top 10 Health Technology Hazards
Jul 30, 2026 - 57:26
Radio and PodcastLive Radio & PodcastsHealth
You Got a 483 from the FDA. Now what?
In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences , we’re discussing what the process should be for a company once they receive a 483 or warning letter from the FD...
Related Episodes
Continue listening to more episodes from Medtech Matters.
Measuring Regulatory/Quality Team Member Performance
Jun 3, 2026 - 62:20
FDA's Third-Party Review Program
May 14, 2026 - 61:00
Triaging Your QMS: Considerations Based on the New QMSR
Apr 17, 2026 - 59:19
A Deep Dive into E&L and Biocomp Testing
Mar 11, 2026 - 22:09
Planning for FDA Shutdowns Now and in the Future
Oct 27, 2025 - 57:28
Should Wellness Products Come with a Warning?
Sep 11, 2025 - 66:02
3 Most Common Premarket (Postmarket?) Review Issues FDA Sees
Jun 25, 2025 - 53:16